Bausch Health Companies Inc (BHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.73 is considered Undervalued compared with the five-year average of 3.15. The fair price of Bausch Health Companies Inc (BHC) is between 18.86 to 31.11 according to relative valuation method. Compared to the current price of 5.95 USD , Bausch Health Companies Inc By Undervalued By 68.45%.

Relative Value

Fair Zone

18.86-31.11

Current Price：5.95

68.45%

Undervalued

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

Unlock 5-Year Valuation Change

Is Bausch Health Companies Inc (BHC) at a historical peak or a rare bargain? Access the full 5-year trend to find out.

Unlock Now

Bausch Health Companies Inc (BHC) has a current Price-to-Book (P/B) ratio of -4.73. Compared to its 3-year average P/B ratio of -2.94, the current P/B ratio is approximately 60.63% higher. Relative to its 5-year average P/B ratio of -13.56, the current P/B ratio is about -65.14% higher. Bausch Health Companies Inc (BHC) has a Forward Free Cash Flow (FCF) yield of approximately 40.99%. Compared to its 3-year average FCF yield of 27.07%, the current FCF yield is approximately 51.41% lower. Relative to its 5-year average FCF yield of 16.14%, the current FCF yield is about 154.02% lower.

Competitors Valuation Multiple

AI Analysis

The average P/S ratio for BHC competitors is 1.83, providing a benchmark for relative valuation. Bausch Health Companies Inc Corp (BHC.N) exhibits a P/S ratio of 0.26, which is -86.02% above the industry average. Given its robust revenue growth of 9.26%, this premium appears unsustainable.

P/E

P/S

EV/EBITDA

EV/EBIT

Earnings Growth

Market Cap

Performance Decomposition

AI Analysis

Market capitalization of BHC increased by 0.00% over the past 1 year(s). The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.

The secondary factor is the Unknown, contributed 0.00% to the performance.

Overall, the performance of BHC in the past 1 year(s) is driven by Unknown.

People Also Watch

Frequently Asked Questions

Is BHC currently overvalued or undervalued?

Bausch Health Companies Inc (BHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.73 is considered Undervalued compared with the five-year average of 3.15. The fair price of Bausch Health Companies Inc (BHC) is between 18.86 to 31.11 according to relative valuation method. Compared to the current price of 5.95 USD, Bausch Health Companies Inc is Undervalued By 68.45%.

What is Bausch Health Companies Inc (BHC) fair value?

BHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. The fair price of Bausch Health Companies Inc (BHC) is between 18.86 to 31.11 according to relative valuation method.

How does BHC's valuation metrics compare to the industry average?

The average P/S ratio for BHC's competitors is 1.83, providing a benchmark for relative valuation. Bausch Health Companies Inc Corp (BHC) exhibits a P/S ratio of 0.26, which is -86.02% above the industry average. Given its robust revenue growth of 9.26%, this premium appears unsustainable.

What is the current P/B ratio for Bausch Health Companies Inc (BHC) as of Mar 03 2026?

As of Mar 03 2026, Bausch Health Companies Inc (BHC) has a P/B ratio of -4.73. This indicates that the market values BHC at -4.73 times its book value.

What is the current FCF Yield for Bausch Health Companies Inc (BHC) as of Mar 03 2026?

As of Mar 03 2026, Bausch Health Companies Inc (BHC) has a FCF Yield of 40.99%. This means that for every dollar of Bausch Health Companies Inc's market capitalization, the company generates 40.99 cents in free cash flow.

What is the current Forward P/E ratio for Bausch Health Companies Inc (BHC) as of Mar 03 2026?

As of Mar 03 2026, Bausch Health Companies Inc (BHC) has a Forward P/E ratio of 1.73. This means the market is willing to pay $1.73 for every dollar of Bausch Health Companies Inc's expected earnings over the next 12 months.

What is the current Forward P/S ratio for Bausch Health Companies Inc (BHC) as of Mar 03 2026?

As of Mar 03 2026, Bausch Health Companies Inc (BHC) has a Forward P/S ratio of 0.26. This means the market is valuing BHC at $0.26 for every dollar of expected revenue over the next 12 months.

BHC Valuation